Johnson Pharmacare Fair Value
Johnson Pharmacare fair value. Johnson Pharmacare (JOHNPHARMA) average fair value is ₹0.11 across 1 valuation models — Price-to-Sales Valuation, vs a current market price of ₹0.45 (-75.56%), fair value range ₹0.11–₹0.11. Check JOHNPHARMA market cap trends to track the company's total market size over time.
Fair Value Analysis Export
JOHNPHARMA Fair Value vs Current Price — Valuation Summary
JOHNPHARMA average fair value, fair value range, price gap and valuation status across 1 models: Price-to-Sales Valuation. Explore JOHNPHARMA value investing to estimate fundamental worth using multiple valuation models.
Price-to-Sales Valuation
JOHNPHARMA Fair Value Analysis — Data Sources & Coverage
Johnson Pharmacare financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit Johnson Pharmacare share price today.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
JOHNPHARMA vs Commercial Services Sector Peers — P/E, P/B & Market Cap
Johnson Pharmacare P/E ratio, P/B ratio and market capitalisation vs Commercial Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Viksit Engineering | VIKSHEN | - | - | - |
| Real Growth Corporation | RGCORP | - | - | - |
| Pulsar International | PULSRIN | -38.0 | 0.34 | ₹17 |
| Getalong Enterprise | GETALONG | 19.73 | 0.7 | ₹11 |
| Encompass Design | ENCOMPAS | - | 4.06 | ₹340 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.